PXR activation attenuates liver fibrosis by down-regulating LECT2 and disrupting β-catenin/TCF4 interaction

Gao, Y; Fan, SC; Zhao, PF; Zhou, YY; Li, HL; Li, X; Cai, CH; Huang, M; Bi, HC

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023; 385 ():